Comments on: "Potentially Inappropriate Medication Use in Patients With Parkinson's Disease: Analysis of Korean National Health Insurance Claims Data". [PDF]
Ryoo N.
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Taiwan's National Health Insurance Research Database (NHIRD): in the Era of Artificial Intelligence, Causal Inference, and Data Security. [PDF]
Hsieh CY +6 more
europepmc +1 more source
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
Epidemiology, Comorbidities, and Healthcare Costs of Prader-Willi Syndrome in South Korea Using the Korean National Health Insurance Service Database. [PDF]
Yang A +4 more
europepmc +1 more source
Differential Effects of the COVID-19 Pandemic on Surgical Utilization by Procedure Type: Analysis of Korean National Health Insurance Data [2017-2021]. [PDF]
Ko SW +5 more
europepmc +1 more source
State of readiness: National health insurance implementation in hospitals, Gauteng province. [PDF]
Mudzweda AD, Simbeni TV, Mogale NM.
europepmc +1 more source
National Health Insurance exposed.
openaire +2 more sources
Hypertension Care Quality and Incidence of Complications Among Hypertensive Patients With Disabilities in Korea: An Analysis of a Cohort Study Using National Health Insurance Data. [PDF]
Lee HY +5 more
europepmc +1 more source

